{'text': '\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMitogen-Activated Protein Kinases and Mitogen Kinase Phosphatase 1: A Critical Interplay in Macrophage Biology\n\n\nMINI REVIEW\npublished: 28 June 2016\n\ndoi: 10.3389/fmolb.2016.00028\n\nFrontiers in Molecular Biosciences | www.frontiersin.org 1 June 2016 | Volume 3 | Article 28\n\nEdited by:\n\nAna Cuenda,\n\nSpanish National Research Council,\n\nSpain\n\nReviewed by:\n\nEusebio Perdiguero,\n\nUniversity Pompeu Fabra, Spain\n\nJose M. Lizcano,\n\nUniversitat Autonoma de Barcelona,\n\nSpain\n\n*Correspondence:\n\nAntonio Celada\n\nacelada@ub.edu\n\nSpecialty section:\n\nThis article was submitted to\n\nCellular Biochemistry,\n\na section of the journal\n\nFrontiers in Molecular Biosciences\n\nReceived: 15 February 2016\n\nAccepted: 13 June 2016\n\nPublished: 28 June 2016\n\nCitation:\n\nLloberas J, Valverde-Estrella L, Tur J,\n\nVico T and Celada A (2016)\n\nMitogen-Activated Protein Kinases\n\nand Mitogen Kinase Phosphatase 1: A\n\nCritical Interplay in Macrophage\n\nBiology. Front. Mol. Biosci. 3:28.\n\ndoi: 10.3389/fmolb.2016.00028\n\nMitogen-Activated Protein Kinases\nand Mitogen Kinase Phosphatase 1:\nA Critical Interplay in Macrophage\nBiology\nJorge Lloberas, Lorena Valverde-Estrella, Juan Tur, Tania Vico and Antonio Celada*\n\nDepartament of Cell Biology, Physiology and Immunology, Universitat de Barcelona, Barcelona, Spain\n\nMacrophages are necessary in multiple processes during the immune response or\n\ninflammation. This review emphasizes the critical role of the mitogen-activated protein\n\nkinases (MAPKs) and mitogen kinase phosphatase-1 (MKP-1) in the functional activities\n\nof macrophages. While the phosphorylation of MAPKs is required for macrophage\n\nactivation or proliferation, MKP-1 dephosphorylates these kinases, thus playing a\n\nbalancing role in the control of macrophage behavior. MKP-1 is a nuclear-localized\n\ndual-specificity phosphatase whose expression is regulated at multiple levels, including\n\nat the transcriptional and post-transcriptional level. The regulatory role of MKP-1 in\n\nthe interplay between MAPK phosphorylation/dephosphorylation makes this molecule\n\na critical regulator of macrophage biology and inflammation.\n\nKeywords: kinases, phosphatases, inflammation, macrophages, immune response, signal transduction\n\nMACROPHAGES A KEY ELEMENT OF THE IMMUNE SYSTEM\n\nMonocytes are the precursors of macrophages and they originate from undifferentiated stem cells\nin the bone marrow. Differentiation is induced in response to growth factors such as M-CSF, IL-3,\nand GM-CSF. M-CSF being the only specific one because the M-CSF receptor (CSF1R, M-CSF-R,\nor CD115 is encoded by the c-fms proto-oncogene) is present only in the monocyte/macrophage\nlineage. Monocytes reach all the tissues in the body via the blood and then they become\nmacrophages (Epelman et al., 2014). In response to various factors, including cytokines, cell-cell\ncontacts, and extracellular matrix interactions, macrophages differentiate to more specialized cells,\ndepending on the tissue. For example, in response to RANKL, these cells differentiate to osteoclasts\nin the bone (Edwards andMundy, 2011), to Kupffer cells in the liver, to Langerhans cells in the skin,\nto bone marrow macrophages in the bone, and to crypt macrophages in the intestine. The activities\nof differentiated macrophages vary in function of the tissue. The interaction of macrophages with\nfactors such as GM-CSF, IL-4, and TGF-β induces differentiation to dendritic cells. These cells are\nkey elements in antigen presentation in the lymph node a process that induces T cell activation\nand the acquired immune response. The immune system responds to stress induced by chemical,\nphysical, and infectious agents by producing inflammation. In this process, macrophages play a\nkey role, initially through their capacity to remove bacteria or parasites. This activity is achieved\nthrough many components that can indirectly damage the surrounding tissues. After this pro-\ninflammatory activity (classical activation or M1), macrophages remove all the damaged tissues\nand start the reconstruction process. In this anti-inflammatory phase (alternative activation orM2),\nmacrophages prompt the synthesis of the extracellular matrix and cell growth (Dey et al., 2014).\n\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org/Molecular_Biosciences/editorialboard\nhttp://www.frontiersin.org/Molecular_Biosciences/editorialboard\nhttp://www.frontiersin.org/Molecular_Biosciences/editorialboard\nhttp://www.frontiersin.org/Molecular_Biosciences/editorialboard\nhttp://dx.doi.org/10.3389/fmolb.2016.00028\nhttp://crossmark.crossref.org/dialog/?doi=10.3389/fmolb.2016.00028&domain=pdf&date_stamp=2016-06-28\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org\nhttp://www.frontiersin.org/Molecular_Biosciences/archive\nhttps://creativecommons.org/licenses/by/4.0/\nmailto:acelada@ub.edu\nhttp://dx.doi.org/10.3389/fmolb.2016.00028\nhttp://journal.frontiersin.org/article/10.3389/fmolb.2016.00028/abstract\nhttp://loop.frontiersin.org/people/347393/overview\nhttp://loop.frontiersin.org/people/334647/overview\nhttp://loop.frontiersin.org/people/260213/overview\n\n\nLloberas et al. Macrophages and Mitogen Kinase Phosphatase 1\n\nUnder physiological conditions, monocytes show the Ly6C−\n\nand CD43++ phenotype in mice and CD14− and CD16++\n\nphenotype in humans (Ziegler-Heitbrock et al., 2010). Localized\naround blood vessels, these cells serve to monitor healthy tissues.\nWhen homeostasis is altered, they enter the affected tissues to\ninitiate an early immune response. During the first 24 h of this\nresponse, the inflammatory loci are invaded first by neutrophils\nand then by monocytes carrying the Ly6C++ CD43− phenotype\nin mice and the CD14++ CD16− phenotype in humans. These\nmonocytes trigger the pro- and anti-inflammatory activities\nmentioned earlier. The same macrophages that are polarized to\npro-inflammatory action become anti-inflammatory a few days\nlater (Arnold et al., 2007; Takeuch and Akira, 2011). Interestingly,\npro-inflammatory activity by agents such IFN-γ or LPS block\nmacrophage proliferation (Xaus et al., 1999). However, during\nanti-inflammatory activation, tissue macrophages proliferate\nlocally (Arnold et al., 2007) in a processmediated by IL-4 (Jenkins\net al., 2011).\n\nMAPKs AND MACROPHAGE BIOLOGY\n\nMAPKs have been conserved over evolution; however, the\nsubcellular compartmentalization and the kinetics of MAPK\nactivation are cell-type specific, and these kinases orchestrate\na range of cellular responses. One of the critical issues in\nmacrophage biology, as in most cell types, is their capacity to\nrespond to stimuli and to proliferate. Although M-CSF, GM-\nCSF, and IL-3 induce macrophage proliferation, M-CSF is the\nonly specific grow factor for these cells. M-CSF interacts with its\nreceptor-specific receptor CSF1R on the cell surface and induces\nthe activation of signal transduction. The interaction is followed\nby receptor dimerization, which leads to the autophosphorylation\nof tyrosine residues in the intracellular domain and the\nrecruitment of signaling molecules (Yu et al., 2012). Macrophage\nproliferation required the stimulation of the MAPK signaling\npathway (Pixley and Stanley, 2004). These serine/threonine\nkinases are induced by external signals, and they play a critical\nrole in regulating the growth, activation, differentiation, and\napoptosis of various types of cells. MAPK activation calls for\nphosphorylation on the threonine and tyrosine residues situated\nin the activation loop. Upon phosphorylation, these kinases\nregulate transcription factors such as Ets-1, Elk/TCF, and AP-\n1, all of which are involved in immediate, early and late gene\nexpression (Yoon and Seger, 2006), and also in protein expression\nby regulating the stability, transport or translocation of mRNA\nspecies that contain AU-rich elements (Wang and Liu, 2007). In\nresponse to growth factors, ERK-1/2, c-Jun NH2-terminal kinase\n1 (JNK-1), and p38 are activated in macrophages. However, for\nthe proliferation of these cells, only ERK-1/2 phosphorylation\nis required (Jaworowski et al., 1999; Valledor et al., 2000a;\nSanchez-Tillo et al., 2007). The activation/phosphorylation of\nRas is necessary to phosphorylate ERK-1/2 and the downstream\ntargets such as the ribosomal S6 kinases and mitogen- and\nstress-activated kinases 1 and 2 (Murphy and Blenis, 2006).\nActivated ERK-1/2 translocate to the nucleus and, by means\n\nof phosphorylation, activate a number of transcription factors\n\nthat regulate genes involved in proliferation. Remarkably,\nM-CSF triggers other pathways independent of MAPKs to\ninduce macrophage survival through the phosphorylation of\nphosphoinositide 3-kinase which prompts the translocation and\nactivation of Akt (Comalada et al., 2004).\n\nLipopolysaccharide (LPS) is a powerful inflammatory signal\npresent in the membrane of Gram-negative bacteria. It regulates\nthe expression of many genes, including TNF-α, which causes\nseptic shock when present in large amounts. ERK-1/2 becomes\nphosphorylated through the interaction of LPS with LPS binding\nprotein (a serum protein), CD14, and TLR4 (membrane proteins\nin macrophages; Valledor et al., 2000b). The inhibition of this\nphosphorylation blocks the production of TNF-α and IL-1β. This\nobservation serves to demonstrate the role of these twomolecules\nin macrophage activation (Valledor et al., 2000a).\n\nIFN-γ, a major endogenous macrophage activator, not only\nrequires Stat1 for signaling but also MAPKs. At early times\n(30 min), p38 is activated strongly, but ERK-1/2 and JNK-\n1 become phosphorylated between 2 and 5 h. Although\np38 and ERK-1/2 regulate the expression of genes of the\ninnate response, such as chemokines, TNF-α, and inducible\nNO synthase, the genes involved in antigen presentation are\nregulated by JNK-1 (Valledor et al., 2008b). These results\nemphasize the diversity of MAPK kinetics and activity in\nmacrophages.\n\nThe kinetics of MAPK phosphorylation with respect to the\nproliferation or functional activation of macrophages may be\nassociated with various factors, such as cell-surface receptor\nconcentration and the different pathways used after ligand-\nreceptor engagement (Murphy and Blenis, 2006). The induction\nof ERK-1/2 phosphorylation by M-CSF or LPS involves the same\nmolecules, namely Ras, Raf, and MEK 1/2 (Casals-Casas et al.,\n2009). However, the early steps differ. While M-CSF receptor\nencloses a tyrosine kinase domain in the intra-cytoplasmic\nregion, thus inducing rapid phosphorylation, LPS interacts with\nLPS-binding protein CD14, and finally TLR4 and requires more\ntime to initiate the phosphorylation (Kolch, 2005).\n\nTHE MKP-1 PHOSPHATASE AND ITS\nREGULATION\n\nMKP-1 phosphatase, also called dual specificity phosphatase 1\n(DUSP1), is expressed ubiquitously. However, it is regulated in\na cell-context manner and is able to dephosphorylate tyrosine\nor serine/threonine residues. MKPs dephosphorylate and\nconsequently inactivate ERK-1/2 (Pouyssegur and Lenormand,\n2003), p38, MAPKs (Kaiser et al., 2004), and JNKs (Sanchez-\nPerez et al., 1998). At least 11 MKP family members of these dual\nphosphatases have been found to differ in cellular specificity,\nsubcellular localization, and substrate specificity (Farooq and\nZhou, 2004).\n\nMKP-1 is composed of two domains, one is bound the\nMAPK in the NH2-terminus and the other is the dual-\nspecificity phosphatase domain located in the COOH terminus\n(Camps et al., 2000). This phosphatase localizes exclusively\nto the nucleus through a NH2-terminus LXXLL motif (Wu\n\nFrontiers in Molecular Biosciences | www.frontiersin.org 2 June 2016 | Volume 3 | Article 28\n\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org\nhttp://www.frontiersin.org/Molecular_Biosciences/archive\n\n\nLloberas et al. Macrophages and Mitogen Kinase Phosphatase 1\n\net al., 2005). The catalytic activity is regulated through\ninteraction with MAPKs mediated by a kinase interaction motif\n(Doddareddy et al., 2012).\n\nIn most cases, the induction of phosphatases is a negative\nresponse mechanism of the kinases that triggers the expression\nor activation of the phosphatases. In macrophages, MPK-1\ninduction yields conflicting results. In primary cultures of bone\nmarrow-derived macrophages, LPS-induced MKP-1 expression\nis partially blocked by co-administration of inhibitors of ERK-\n1/2 and p38 (Ananieva et al., 2008) or when macrophage from a\np38 KO mouse are used (Kim et al., 2008). In other studies using\nthe same cell type, the inhibition of the MEK pathway required\nfor M-CSF- or LPS-induced ERK-1/2 phosphorylation was not\nfound to affect MKP-1 expression, thereby showing that this\nexpression is independent of kinase activation (Valledor et al.,\n1999, 2000b).\n\nThe early steps in signal transduction to induce MKP-1\ninvolves the phosphorylation of PKCε (Valledor et al., 1999,\n2000b). Interestingly, the expression of MKP-1 induced by\neither M-CSF or LPS also requires Raf-1 activation, as does the\nphosphorylation of ERK-1/2 (Sanchez-Tillo et al., 2006). Another\nmediator of MKP-1 stimulation is JNK-1, and inactivation of\nthis kinase results in prolonged ERK phosphorylation (Sanchez-\nTillo et al., 2007). Finally, inhibition of mTOR induces MKP-1\nexpression, thereby suggesting that the repression of immunity is\nmediated through MKP-1 (Rastogi et al., 2013).\n\nMKP-1 is not expressed under basal conditions; however, in\nresponse to various stimuli MKP-1 is an immediate early gene\nthat requires transcriptional activation, although its regulation is\nalso mediated at several other levels. In the MKP-1 promoter,\na region containing a CREB/AP-1 box is essential for the\ninduction of transcription through a variety of different stimuli\n(Arthur et al., 2004; Ananieva et al., 2008; Cho et al., 2008;\nKim et al., 2008; Casals-Casas et al., 2009). Upon activation\nby M-CSF or LPS, this box is occupied by phosphorylated\nCREB and c-Jun. It has been reported that the phosphorylation\nof CREB is mediated by p38 (Kamata et al., 2005) and by\nERK-1/2. However, this phosphorylation is not direct but\nmediated through MSK1/2 activated by either ERK-1/2 or p38\n(Ananieva et al., 2008; Kim et al., 2008). However, it has been\nreported that the inhibition of ERK does not block MKP-1\ninduction by M-CSF and LPS (Valledor et al., 1999, 2000b).\nOther studies have described that CREB phosphorylation is\nmediated by M-CSF-induced PI-3K (Kanagasundaram et al.,\n1999) or by LPS-activated PKA (Zhong et al., 1997). Vitamin\nD induces MKP-1, thus inhibiting pro-inflammatory cytokine\nproduction, and the binding of the vitamin D receptor at\nthe vitamin D response element in the MKP-1 promoter is\nincreased (Zhang et al., 2012). In the context of the proliferation\nvs. activation issue, IFN-γ, the major endogenous activator\nof macrophages, inhibits M-CSF-induced MKP-1 expression\n(Valledor et al., 2008a). The inhibition is mediated through\nSTAT1, but no such repressive activity has been reported for this\ntranscription factor. Transcription, in turn, calls for epigenetic\nmodifications or chromatin remodeling on the MKP-1 promoter\nregion. Through phosphorylation and acetylation of histone H3,\nchromatin is modified, thereby increasing the binding of RNA\n\npolymerase II and inducing MKP-1 transcription (Li et al., 2001;\nFigure 1).\n\nMKP-1 mRNA in macrophages has a very short half-life\n(Valledor et al., 1999). In other cellular models, the short mRNA\nhalf-life has been related to AU-rich 3′ untranslated regions and\nthe RNA binding proteins HuR and NF90 (Kuwano et al., 2008).\nIt seems that NF90 represses the translation of mRNAs bearing\nthe AU-rich signature sequence without affecting their half-lives\n(Kuwano et al., 2010). Tristetraprolin binds to these AU-rich\nsequences of MKP-1 and thus forms part of a negative feedback\nloop to limit the mRNA half-life (Emmons et al., 2008). In\nfact, tristetraprolin expression is suppressed by MKP-1 through\ninhibition of p38 (Huotari et al., 2012).\n\nThe activity of MKP-1 can be modified by stabilization\nof his on protein, which is determined by its ERK-mediated\nphosphorylation through a degradation pathway independent of\npolyubiquitination (Crowell et al., 2014). If Ser359 and Ser364\nbecome phosphorylated, the protein is stabilized (Brondello et al.,\n1999); however, if phosphorylation occurs in Ser298 and Ser323,\nthen proteosomal degradation is facilitated (Lin et al., 2003).\nWe should mention that glucocorticoids not only induce the\ntranscription of MKP-1 but also attenuate their proteasomal\ndegradation (Kassel et al., 2001; Figure 1).\n\nMetabolic stress in monocytes and macrophages induces\nNox4, an inducible NADPH oxidase that promotes MKP-\n1-S-glutathionylation, resulting in MKP1 inactivation and\nsubsequent proteasomal degradation (Kim et al., 2012). This\nobservation shows that a redox-regulated mechanism links\noxidative stress directly to metabolic disorders and macrophage\nhyperactivity.\n\nThe repressive cytokines IL-10 and TGF-β block most\nimmune responses and increase LPS-dependent MKP-1\ninduction, thereby enhancing the degree and duration of the\nphosphatase and consequently dephosphorylating MAPKs with\nthe consequent inhibition of inflammatory cytokine production\n(Jono et al., 2003; Hammer et al., 2005). Micro-RNA-101\n(miR-101) and miR-210 transfections reduce LPS-dependent\ninduction of MKP-1 and also prolong the phosphorylation of\np38 and JNK (Zhu et al., 2010; Jin et al., 2014).\n\nGlucocorticoids are one of the major families of inhibitors of\nthe immune response used in clinical practice. Remarkably, these\ndrugs increase the expression and decrease the degradation of\nMKP-1. Consequently, MKP-1 dephosphorylates MAPKs, thus\ndecreasing the activity of these kinases, as well as reducing\nmacrophage activation (Kassel et al., 2001; Shipp et al., 2010).\nHowever, the observation that MKP-1 KO mice with enhanced\ncytokine expression remain sensitive to glucocorticoids suggests\nthat the drug targets molecules other than MKP-1 (Maier et al.,\n2007; Wang et al., 2008).\n\nIn response to LPS, MKP-1 is acetylated by p300/CBP on\nlysine 57 within its substrate-binding domain, thus increasing its\ninteraction and dephosphorylation of p38 (Cao et al., 2008). This\nobservation reveals another level of regulation of the functional\nactivity mediated by histone deacetylase isoforms (HDAC1,\nHDAC2, and HDAC3; Jeong et al., 2014).\n\nTherefore, the mechanisms regulating MKP-1 expression are\ncritical in determining the duration of MAPK phosphorylation\n\nFrontiers in Molecular Biosciences | www.frontiersin.org 3 June 2016 | Volume 3 | Article 28\n\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org\nhttp://www.frontiersin.org/Molecular_Biosciences/archive\n\n\nLloberas et al. Macrophages and Mitogen Kinase Phosphatase 1\n\nFIGURE 1 | The regulation of MKP-1 arises by multiple mechanisms, including transcription, mRNA stability, and protein acetylation and degradation.\n\nThis last depends of different sites of phosphorylation.\n\nand the length of the immune response (Manetsch et al., 2012;\nTomida et al., 2015).\n\nTHE SWITCH BETWEEN PROLIFERATION\nAND ACTIVATION IS MEDIATED BY MKP-1\n\nThe activation and proliferation of macrophages are reciprocally\nexclusive processes (Xaus et al., 1999); however, both require\nERK-1/2 phosphorylation, although with distinct kinetics.\nFor macrophage proliferation, ERK-1/2 phosphorylation\noccurs with a prompt peak around 5 min, while for\nactivation the phosphorylation takes place later, around 15\nmin (Valledor et al., 2000a; Suzu et al., 2007; Figure 2).\nThe time course of ERK-1/2 dephosphorylation differs for\ngrowth factors and activating molecules, occurring 30 min\nafter phosphorylation for M-CSF-induced proliferation\nand 90 min for LPS-induced functional activation. MAPK\n\nphosphorylation is regulated by the dominant action of\nprotein phosphatases, as evidenced by phosphorylation\nbeing reversible even in the continued presence of activating\n\nstimuli.\nBoth stimuli triggering proliferation and functional activation\n\ninduce nuclear MKP-1 (Valledor et al., 1999, 2000b). The\ntranscription of MKP-1 follows the same kinetics by M-CSF or\nLPS, producing early or late mRNA, depending on the stimuli.\nRegardless of whether macrophages are treated with M-CSF or\nLPS, ERK-1/2 dephosphorylation is associated only with the\ninduction of MKP-1 (Valledor et al., 2008a; Figure 2). This\ninduction requires the binding and phosphorylation of CREB and\nc-Jun, and the kinetics of these two molecules correlates to the\ndifferent times courses ofMKP-1 expression. The distinct kinetics\nof dephosphorylation suggests that the critical factor that allows\nLPS or IFN-γ to inhibit macrophage proliferation is related to the\nduration of ERK phosphorylation. This hypothesis was tested by\ninhibiting MKP-1 expression. However, Mkp-1 knockout (KO)\n\nFrontiers in Molecular Biosciences | www.frontiersin.org 4 June 2016 | Volume 3 | Article 28\n\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org\nhttp://www.frontiersin.org/Molecular_Biosciences/archive\n\n\nLloberas et al. Macrophages and Mitogen Kinase Phosphatase 1\n\nFIGURE 2 | Interplay between MAPKs and MKP-1. (A) The kinetics of\n\nMKP-1 induction determines the different time courses of ERK phosphorylation\n\ngoverning the proliferation or the functional activation of macrophages. The\n\nrepression of MKP-1 expression prolongs ERK-1/2 phosphorylation and\n\nblocks proliferation (Valledor et al., 1999, 2000a,b, 2008a; Xaus et al., 2001;\n\nSanchez-Tillo et al., 2007). (B) For balanced activation MKP-1 is required. The\n\nabsence of MKP-1 induces an excess of activation.\n\nmice cannot be used for this purpose because compensatory\nmechanisms replace the role of MKP-1 in proliferation. In\nfact, in contrast to wild-type cells in which MKP-4 is not\ninduced by M-CSF, in MKP-1 deficient macrophages, there is\nan early MKP-4 response to M-CSF. By using siRNA, it was\nobserved that the inhibition of MKP-1 expression extends ERK-\n1/2 phosphorylation and blocks M-CSF-dependent proliferation\n(Valledor et al., 2008a).\n\nThe inhibition of proliferation induced by IFN-γ stimulation\ncorrelates with extended ERK-1/2 phosphorylation induced by\nM-CSF and is due to the inhibition of MKP-1 expression\n(Valledor et al., 2008a). Interestingly, this inhibition is mediated\nby STAT1. This observation would suggest that this transcription\nfactor represses some genes.\n\nTheM-CSF-dependent induction of MKP-1 expression can be\naltered by other agents. MKP-1 expression can be inhibited by\nsignaling through extracellular matrix proteins, such as decorin\nand fibrinogen (Xaus et al., 2001). As result of such inhibition,\nERK phosphorylation is extended, and macrophage proliferation\nis inhibited (Figure 2).\n\nOTHER ACTIVITIES REGULATED BY\nMKP-1\n\nMKP-1 KO mice show extended MAPK phosphorylation that\ncorrelates with an increased expression of cytokines such as\n\nTNF-α, IL-6, and IL-12, all of which increase inflammation\n(mice exhibit kidney failure, severe hypotension, inflammatory\ninfiltrates in the lung and other tissues, and impaired circulation\ncompared with wild-type mice) and cause higher susceptibility\nto endotoxic shock (Chi et al., 2006; Hammer et al., 2006,\n2010; Salojin et al., 2006; Zhao et al., 2006; Frazier et al.,\n2009; Rodriguez et al., 2010). In a microarray of 14,000 genes\nfrom mkp-1−/− mouse spleen cells, 608 genes were found to\nbe upregulated (Hammer et al., 2006). The absence of MKP-\n1 produces the longest p38 phosphorylation, which in turn\nincreases C/EBPβ phosphorylation, a critical process in several\nLPS-induced genes (Serrat et al., 2014). Another mechanism to\nby which to increase the gene expression of natural immunity\nin the absence of MKP-1 may be related to histones such as H3,\nwhich is a substrate of MKP-1 (Kinney et al., 2009). The loss of\nhistone dephosphorylation may affect the transcription of several\ngenes.\n\nInterestingly, the half-lives of mRNAs of several cytokines,\nincluding IL-6, IL-10, and TNF-α, seem to be controlled by\nMKP-1 through translocation of RNA binding proteins from\nthe nucleus to the cytosol (Yu et al., 2011). Recent data shows\nthat MKP-1 modulates the activity of the cytokine mRNA by\ndestabilizing the phosphorylation status of tristetraprolin, an\nRNA-destabilizing protein (Smallie et al., 2015).\n\nIn conclusion, in this review we have addressed the critical\nissue of the duration of ERK-1/2 kinase phosphorylation\nand its role in mediating macrophage proliferation or\nfunctional activation. The duration of the phosphorylation\nstate is determined by the induction of MKP-1, thus\nmaking MKP-1 one of the critical regulators of macrophage\nbiology.\n\nAUTHOR CONTRIBUTIONS\n\nJL: review literature, discuss with the other collaborators, made\npart of the original data and draw the graphics. LV, JT, and\nTV: review literature, discuss with the other collaborators and\nmade part of the original data. AC: review literature, discuss with\nthe other collaborators, made the original data and wrote the\nmanuscript.\n\nACKNOWLEDGMENTS\n\nThis study was supported by a grant from the Plan Nacional del\nMinisterio de Economia y Competividad SAF2014-52887-R to AC\nand JL.\n\nFrontiers in Molecular Biosciences | www.frontiersin.org 5 June 2016 | Volume 3 | Article 28\n\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org\nhttp://www.frontiersin.org/Molecular_Biosciences/archive\n\n\nLloberas et al. Macrophages and Mitogen Kinase Phosphatase 1\n\nREFERENCES\n\nAnanieva, O., Darragh, J., Johansen, C., Carr, J. M., Mcilrath, J., Park, J. M., et al.\n\n(2008). The kinases MSK1 and MSK2 act as negative regulators of Toll-like\n\nreceptor signaling. Nat. Immunol. 9, 1028–1036. doi: 10.1038/ni.1644\n\nArnold, L., Henry, A., Poron, F., Baba-Amer, Y., Van Rooijen, N., Plonquet, A.,\n\net al. (2007). Inflammatory monocytes recruited after skeletal muscle injury\n\nswitch into antiinflammatory macrophages to support myogenesis. J. Exp. Med.\n\n204, 1057–1069. doi: 10.1084/jem.20070075\n\nArthur, J. S., Fong, A. L., Dwyer, J. M., Davare, M., Reese, E., Obrietan, K., et al.\n\n(2004).Mitogen- and stress-activated protein kinase 1mediates cAMP response\n\nelement-binding protein phosphorylation and activation by neurotrophins. J.\n\nNeurosci. 24, 4324–4332. doi: 10.1523/JNEUROSCI.5227-03.2004\n\nBrondello, J. M., Pouyssegur, J., and Mckenzie, F. R. (1999). Reduced MAP kinase\n\nphosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation.\n\nScience 286, 2514–2517. doi: 10.1126/science.286.5449.2514\n\nCamps, M., Nichols, A., and Arkinstall, S. (2000). Dual specificity phosphatases: a\n\ngene family for control of MAP kinase function. FASEB J. 14, 6–16.\n\nCao,W., Bao, C., Padalko, E., and Lowenstein, C. J. (2008). Acetylation of mitogen-\n\nactivated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J.\n\nExp. Med. 205, 1491–1503. doi: 10.1084/jem.20071728\n\nCasals-Casas, C., Alvarez, E., Serra, M., de la Torre, C., Farrera, C., Sanchez-Tillo,\n\nE., et al. (2009). CREB and AP-1 activation regulates MKP-1 induction by\n\nLPS or M-CSF and their kinetics correlate with macrophage activation versus\n\nproliferation. Eur. J. Immunol. 39, 1902–1913. doi: 10.1002/eji.200839037\n\nChi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., et al.\n\n(2006). Dynamic regulation of pro- and anti-inflammatory cytokines byMAPK\n\nphosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci.\n\nU.S.A. 103, 2274–2279. doi: 10.1073/pnas.0510965103\n\nCho, I. J., Woo, N. R., and Kim, S. G. (2008). The identification of C/EBPbeta\n\nas a transcription factor necessary for the induction of MAPK phosphatase-\n\n1 by toll-like receptor-4 ligand. Arch. Biochem. Biophys. 479, 88–96. doi:\n\n10.1016/j.abb.2008.08.007\n\nComalada, M., Xaus, J., Sanchez, E., Valledor, A. F., and Celada, A.\n\n(2004). Macrophage colony-stimulating factor-, granulocyte-macrophage\n\ncolony-stimulating factor-, or IL-3-dependent survival of macrophages,\n\nbut not proliferation, requires the expression of p21(Waf1) through the\n\nphosphatidylinositol 3-kinase/Akt pathway. Eur. J. Immunol. 34, 2257–2267.\n\ndoi: 10.1002/eji.200425110\n\nCrowell, S., Wancket, L. M., Shakibi, Y., Xu, P., Xue, J., Samavati, L., et al. (2014).\n\nPost-translational regulation of mitogen-activated protein kinase phosphatase\n\n(MKP)-1 and MKP-2 in macrophages following lipopolysaccharide\n\nstimulation: the role of the C termini of the phosphatases in determining\n\ntheir stability. J. Biol. Chem. 289, 28753–28764. doi: 10.1074/jbc.M114.591925\n\nDey, A., Allen, J., and Hankey-Giblin, P. A. (2014). Ontogeny and polarization\n\nof macrophages in inflammation: blood monocytes versus tissue macrophages.\n\nFront. Immunol. 5:683. doi: 10.3389/fimmu.2014.00683\n\nDoddareddy, M. R., Rawling, T., and Ammit, A. J. (2012). Targeting mitogen-\n\nactivated protein kinase phosphatase-1 (MKP-1): structure-based design of\n\nMKP-1 inhibitors and upregulators. Curr. Med. Chem. 19, 163–173. doi:\n\n10.2174/092986712803414196\n\nEdwards, J. R., and Mundy, G. R. (2011). Advances in osteoclast biology: old\n\nfindings and new insights from mouse models. Nat. Rev. Rheumatol. 7,\n\n235–243. doi: 10.1038/nrrheum.2011.23\n\nEmmons, J., Townley-Tilson, W. H., Deleault, K. M., Skinner, S. J., Gross, R. H.,\n\nWhitfield, M. L., et al. (2008). Identification of TTP mRNA targets in human\n\ndendritic cells reveals TTP as a critical regulator of dendritic cell maturation.\n\nRNA 14, 888–902. doi: 10.1261/rna.748408\n\nEpelman, S., Lavine, K. J., and Randolph, G. J. (2014). Origin and functions\n\nof tissue macrophages. Immunity 41, 21–35. doi: 10.1016/j.immuni.2014.\n\n06.013\n\nFarooq, A., and Zhou, M. M. (2004). Structure and regulation of MAPK\n\nphosphatases. Cell. Signal. 16, 769–779. doi: 10.1016/j.cellsig.2003.12.008\n\nFrazier, W. J., Wang, X., Wancket, L. M., Li, X. A., Meng, X., Nelin, L. D., et al.\n\n(2009). Increased inflammation, impaired bacterial clearance, and metabolic\n\ndisruption after gram-negative sepsis inMkp-1-deficient mice. J. Immunol. 183,\n\n7411–7419. doi: 10.4049/jimmunol.0804343\n\nHammer, M., Echtenachter, B., Weighardt, H., Jozefowski, K., Rose-John, S.,\n\nMannel, D. N., et al. (2010). Increased inflammation and lethality of Dusp1–/–\n\nmice in polymicrobial peritonitis models. Immunology 131, 395–404. doi:\n\n10.1111/j.1365-2567.2010.03313.x\n\nHammer, M., Mages, J., Dietrich, H., Schmitz, F., Striebel, F., Murray, P.\n\nJ., et al. (2005). Control of dual-specificity phosphatase-1 expression in\n\nactivated macrophages by IL-10. Eur. J. Immunol. 35, 2991–3001. doi:\n\n10.1002/eji.200526192\n\nHammer, M., Mages, J., Dietrich, H., Servatius, A., Howells, N., Cato, A. C., et al.\n\n(2006). Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-\n\ninduced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203,\n\n15–20. doi: 10.1084/jem.20051753\n\nHuotari, N., Hommo, T., Taimi, V., Nieminen, R., Moilanen, E., and Korhonen,\n\nR. (2012). Regulation of tristetraprolin expression by mitogen-activated\n\nprotein kinase phosphatase-1. APMIS 120, 988–999. doi: 10.1111/j.1600-\n\n0463.2012.02927.x\n\nJaworowski, A., Wilson, N. J., Christy, E., Byrne, R., and Hamilton, J. A. (1999).\n\nRoles of the mitogen-activated protein kinase family in macrophage responses\n\nto colony stimulating factor-1 addition and withdrawal. J. Biol. Chem. 274,\n\n15127–15133. doi: 10.1074/jbc.274.21.15127\n\nJenkins, S. J., Ruckerl, D., Cook, P. C., Jones, L. H., Finkelman, F. D., Van Rooijen,\n\nN., et al. (2011). Local macrophage proliferation, rather than recruitment from\n\nthe blood, is a signature of TH2 inflammation. Science 332, 1284–1288. doi:\n\n10.1126/science.1204351\n\nJeong, Y., Du, R., Zhu, X., Yin, S., Wang, J., Cui, H., et al. (2014). Histone\n\ndeacetylase isoforms regulate innate immune responses by deacetylating\n\nmitogen-activated protein kinase phosphatase-1. J. Leukoc. Biol. 95, 651–659.\n\ndoi: 10.1189/jlb.1013565\n\nJin, C., Peng, X., Liu, F., Cheng, L., Lu, X., Yao, H., et al. (2014). MicroRNA-\n\n181 expression regulates specific post-transcriptional level of SAMHD1\n\nexpression in vitro. Biochem. Biophys. Res. Commun. 452, 760–767. doi:\n\n10.1016/j.bbrc.2014.08.151\n\nJono, H., Xu, H., Kai, H., Lim, D. J., Kim, Y. S., Feng, X. H., et al.\n\n(2003). Transforming growth factor-beta-Smad signaling pathway negatively\n\nregulates nontypeable Haemophilus influenzae-induced MUC5AC mucin\n\ntranscription via mitogen-activated protein kinase (MAPK) phosphatase-1-\n\ndependent inhibition of p38 MAPK. J. Biol. Chem. 278, 27811–27819. doi:\n\n10.1074/jbc.M301773200\n\nKaiser, R. A., Bueno, O. F., Lips, D. J., Doevendans, P. A., Jones, F., Kimball, T.\n\nF., et al. (2004). Targeted inhibition of p38 mitogen-activated protein kinase\n\nantagonizes cardiac injury and cell death following ischemia-reperfusion in\n\nvivo. J. Biol. Chem. 279, 15524–15530. doi: 10.1074/jbc.M313717200\n\nKamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., and Karin, M. (2005).\n\nReactive oxygen species promote TNFalpha-induced death and sustained JNK\n\nactivation by inhibiting MAP kinase phosphatases. Cell 120, 649–661. doi:\n\n10.1016/j.cell.2004.12.041\n\nKanagasundaram, V., Jaworowski, A., Byrne, R., and Hamilton, J. A.\n\n(1999). Separation and characterization of the activated pool of colony-\n\nstimulating factor 1 receptor forming distinct multimeric complexes with\n\nsignalling molecules in macrophages. Mol. Cell. Biol. 19, 4079–4092. doi:\n\n10.1128/MCB.19.6.4079\n\nKassel, O., Sancono, A., Kratzschmar, J., Kreft, B., Stassen, M., and Cato,\n\nA. C. (2001). Glucocorticoids inhibit MAP kinase via increased expression\n\nand decreased degradation of MKP-1. EMBO J. 20, 7108–7116. doi:\n\n10.1093/emboj/20.24.7108\n\nKim, C., Sano, Y., Todorova, K., Carlson, B. A., Arpa, L., Celada, A., et al.\n\n(2008). The kinase p38 alpha serves cell type-specific inflammatory functions in\n\nskin injury and coordinates pro- and anti-inflammatory gene expression. Nat.\n\nImmunol. 9, 1019–1027. doi: 10.1038/ni.1640\n\nKim, H. S., Ullevig, S. L., Zamora, D., Lee, C. F., and Asmis, R. (2012).\n\nRedox regulation of MAPK phosphatase 1 controls monocyte migration and\n\nmacrophage recruitment. Proc. Natl. Acad. Sci. U.S.A. 109, E2803–E2812. doi:\n\n10.1073/pnas.1212596109\n\nKinney, C. M., Chandrasekharan, U. M., Yang, L., Shen, J., Kinter, M.,\n\nMcdermott, M. S., et al. (2009). Histone H3 as a novel substrate for MAP\n\nkinase phosphatase-1. Am. J. Physiol. Cell Physiol. 296, C242–C249. doi:\n\n10.1152/ajpcell.00492.2008\n\nFrontiers in Molecular Biosciences | www.frontiersin.org 6 June 2016 | Volume 3 | Article 28\n\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org\nhttp://www.frontiersin.org/Molecular_Biosciences/archive\n\n\nLloberas et al. Macrophages and Mitogen Kinase Phosphatase 1\n\nKolch, W. (2005). Coordinating ERK/MAPK signalling through scaffolds and\n\ninhibitors. Nat. Rev. Mol. Cell Biol. 6, 827–837. doi: 10.1038/nrm1743\n\nKuwano, Y., Kim, H. H., Abdelmohsen, K., Pullmann, R. Jr., Martindale, J. L.,\n\nYang, X., et al. (2008). MKP-1 mRNA stabilization and translational control\n\nby RNA-binding proteins HuR and NF90. Mol. Cell. Biol. 28, 4562–4575. doi:\n\n10.1128/MCB.00165-08\n\nKuwano, Y., Pullmann, R. Jr., Marasa, B. S., Abdelmohsen, K., Lee, E. K., Yang,\n\nX., et al. (2010). NF90 selectively represses the translation of target mRNAs\n\nbearing an AU-rich signature motif. Nucleic Acids Res. 38, 225–238. doi:\n\n10.1093/nar/gkp861\n\nLi, J., Gorospe, M., Hutter, D., Barnes, J., Keyse, S. M., and Liu, Y. (2001).\n\nTranscriptional induction of MKP-1 in response to stress is associated with\n\nhistone H3 phosphorylation-acetylation. Mol. Cell. Biol. 21, 8213–8224. doi:\n\n10.1128/MCB.21.23.8213-8224.2001\n\nLin, Y. W., Chuang, S. M., and Yang, J. L. (2003). ERK1/2 achieves\n\nsustained activation by stimulating MAPK phosphatase-1 degradation via\n\nthe ubiquitin-proteasome pathway. J. Biol. Chem. 278, 21534–21541. doi:\n\n10.1074/jbc.M301854200\n\nMaier, J. V., Brema, S., Tuckermann, J., Herzer, U., Klein, M., Stassen, M.,\n\net al. (2007). Dual specificity phosphatase 1 knockout mice show enhanced\n\nsusceptibility to anaphylaxis but are sensitive to glucocorticoids. Mol.\n\nEndocrinol. 21, 2663–2671. doi: 10.1210/me.2007-0067\n\nManetsch, M., Che, W., Seidel, P., Chen, Y., and Ammit, A. J. (2012). MKP-1: a\n\nnegative feedback effector that represses MAPK-mediated pro-inflammatory\n\nsignaling pathways and cytokine secretion in human airway smooth muscle\n\ncells. Cell. Signal. 24, 907–913. doi: 10.1016/j.cellsig.2011.12.013\n\nMurphy, L. O., and Blenis, J. (2006). MAPK signal specificity: the right place at the\n\nright time. Trends Biochem. Sci. 31, 268–275. doi: 10.1016/j.tibs.2006.03.009\n\nPixley, F. J., and Stanley, E. R. (2004). CSF-1 regulation of the wandering\n\nmacrophage: complexity in action. Trends Cell Biol. 14, 628–638. doi:\n\n10.1016/j.tcb.2004.09.016\n\nPouyssegur, J., and Lenormand, P. (2003). Fidelity and spatio-temporal control\n\nin MAP kinase (ERKs) signalling. Eur. J. Biochem. 270, 3291–3299. doi:\n\n10.1046/j.1432-1033.2003.03707.x\n\nRastogi, R., Jiang, Z., Ahmad, N., Rosati, R., Liu, Y., Beuret, L., et al. (2013).\n\nRapamycin induces mitogen-activated protein (MAP) kinase phosphatase-1\n\n(MKP-1) expression through activation of protein kinase B and mitogen-\n\nactivated protein kinase kinase pathways. J. Biol. Chem. 288, 33966–33977. doi:\n\n10.1074/jbc.M113.492702\n\nRodriguez, N., Dietrich, H., Mossbrugger, I., Weintz, G., Scheller, J., Hammer,\n\nM., et al. (2010). Increased inflammation and impaired resistance to\n\nChlamydophila pneumoniae infection in Dusp1(–/–) mice: critical role of IL-6.\n\nJ. Leukoc. Biol. 88, 579–587. doi: 10.1189/jlb.0210083\n\nSalojin, K. V., Owusu, I. B., Millerchip, K. A., Potter, M., Platt, K. A., and\n\nOravecz, T. (2006). Essential role of MAPK phosphatase-1 in the negative\n\ncontrol of innate immune responses. J. Immunol. 176, 1899–1907. doi:\n\n10.4049/jimmunol.176.3.1899\n\nSanchez-Perez, I., Murguia, J. R., and Perona, R. (1998). Cisplatin induces a\n\npersistent activation of JNK that is related to cell death. Oncogene 16, 533–540.\n\ndoi: 10.1038/sj.onc.1201578\n\nSanchez-Tillo, E., Comalada, M., Farrera, C., Valledor, A. F., Lloberas,\n\nJ., and Celada, A. (2006). Macrophage-colony-stimulating factor-induced\n\nproliferation and lipopolysaccharide-dependent activation of macrophages\n\nrequires Raf-1 phosphorylation to induce mitogen kinase phosphatase-1\n\nexpression. J. Immunol. 176, 6594–6602. doi: 10.4049/jimmunol.176.11.6594\n\nSanchez-Tillo, E., Comalada, M., Xaus, J., Farrera, C., Valledor, A. F.,\n\nCaelles, C., et al. (2007). JNK1 Is required for the induction of Mkp1\n\nexpression in macrophages during proliferation and lipopolysaccharide-\n\ndependent activation. J. Biol. Chem. 282, 12566–12573. doi: 10.1074/jbc.M6096\n\n62200\n\nSerrat, N., Sebastian, C., Pereira-Lopes, S., Valverde-Estrella, L., Lloberas, J., and\n\nCelada, A. (2014). The response of secondary genes to lipopolysaccharides\n\nin macrophages depends on histone deacetylase and phosphorylation of\n\nC/EBPbeta. J. Immunol. 192, 418–426. doi: 10.4049/jimmunol.1203500\n\nShipp, L. E., Lee, J. V., Yu, C. Y., Pufall, M., Zhang, P., Scott, D. K.,\n\net al. (2010). Transcriptional regulation of human dual specificity protein\n\nphosphatase 1 (DUSP1) gene by glucocorticoids. PLoS ONE 5:e13754. doi:\n\n10.1371/journal.pone.0013754\n\nSmallie, T., Ross, E. A., Ammit, A. J., Cunliffe, H. E., Tang, T., Rosner, D. R., et al.\n\n(2015). Dual-specificity phosphatase 1 and tristetraprolin cooperate to regulate\n\nmacrophage responses to lipopolysaccharide. J. Immunol. 195, 277–288. doi:\n\n10.4049/jimmunol.1402830\n\nSuzu, S., Hiyoshi, M., Yoshidomi, Y., Harada, H., Takeya, M., Kimura, F., et al.\n\n(2007). M-CSF-mediated macrophage differentiation but not proliferation is\n\ncorrelated with increased and prolonged ERK activation. J. Cell. Physiol. 212,\n\n519–525. doi: 10.1002/jcp.21045\n\nTakeuch, O., and Akira, S. (2011). Epigenetic control of macrophage polarization.\n\nEur. J. Immunol. 41, 2490–2493. doi: 10.1002/eji.201141792\n\nTomida, T., Takekawa, M., and Saito, H. (2015). Oscillation of p38 activity\n\ncontrols efficient pro-inflammatory gene expression. Nat. Commun. 6:8350.\n\ndoi: 10.1038/ncomms9350\n\nValledor, A. F., Arpa, L., Sanchez-Tillo, E., Comalada, M., Casals, C., Xaus, J., et al.\n\n(2008a). IFN-{gamma}-mediated inhibition of MAPK phosphatase expression\n\nresults in prolonged MAPK activity in response to M-CSF and inhibition of\n\nproliferation. Blood 112, 3274–3282. doi: 10.1182/blood-2007-11-123604\n\nValledor, A. F., Comalada, M., Xaus, J., and Celada, A. (2000a). The differential\n\ntime-course of extracellular-regulated kinase activity correlates with the\n\nmacrophage response toward proliferation or activation. J. Biol. Chem. 275,\n\n7403–7409. doi: 10.1074/jbc.275.10.7403\n\nValledor, A. F., Sanchez-Tillo, E., Arpa, L., Park, J. M., Caelles, C., Lloberas, J.,\n\net al. (2008b). Selective roles of MAPKs during the macrophage response to\n\nIFN-gamma. J. Immunol. 180, 4523–4529. doi: 10.4049/jimmunol.180.7.4523\n\nValledor, A. F., Xaus, J., Comalada, M., Soler, C., and Celada, A. (2000b).\n\nProtein kinase C epsilon is required for the induction of mitogen-activated\n\nprotein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages.\n\nJ. Immunol. 164, 29–37. doi: 10.4049/jimmunol.164.1.29\n\nValledor, A. F., Xaus, J., Marques, L., and Celada, A. (1999). Macrophage colony-\n\nstimulating factor induces the expression of mitogen-activated protein kinase\n\nphosphatase-1 through a protein kinase C-dependent pathway. J. Immunol.\n\n163, 2452–2462.\n\nWang, X., and Liu, Y. (2007). Regulation of innate immune response\n\nby MAP kinase phosphatase-1. Cell. Signal. 19, 1372–1382. doi:\n\n10.1016/j.cellsig.2007.03.013\n\nWang, X., Nelin, L. D., Kuhlman, J. R., Meng, X., Welty, S. E., and\n\nLiu, Y. (2008). The role of MAP kinase phosphatase-1 in the protective\n\nmechanism of dexamethasone against endotoxemia. Life Sci. 83, 671–680. doi:\n\n10.1016/j.lfs.2008.09.003\n\nWu, J. J., Zhang, L., and Bennett, A. M. (2005). The noncatalytic amino terminus\n\nof mitogen-activated protein kinase phosphatase 1 directs nuclear targeting\n\nand serum response element transcriptional regulation. Mol. Cell. Biol. 25,\n\n4792–4803. doi: 10.1128/MCB.25.11.4792-4803.2005\n\nXaus, J., Cardo, M., Valledor, A. F., Soler, C., Lloberas, J., and Celada, A. (1999).\n\nInterferon gamma induces the expression of p21 waf-1 and arrests macrophage\n\ncell cycle, preventing induction of apoptosis. Immunity 11, 103–113. doi:\n\n10.1016/S1074-7613(00)80085-0\n\nXaus, J., Comalada, M., Cardo, M., Valledor, A. F., and Celada, A. (2001). Decorin\n\ninhibits macrophage colony-stimulating factor proliferation of macrophages\n\nand enhances cell survival through induction of p27(Kip1) and p21(Waf1).\n\nBlood 98, 2124–2133. doi: 10.1182/blood.V98.7.2124\n\nYoon, S., and Seger, R. (2006). The extracellular signal-regulated kinase: multiple\n\nsubstrates regulate diverse cellular functions. Growth Factors 24, 21–44. doi:\n\n10.1080/02699050500284218\n\nYu, H., Sun, Y., Haycraft, C., Palanisamy, V., and Kirkwood, K. L. (2011). MKP-1\n\nregulates cytokine mRNA stability through selectively modulation subcellular\n\ntranslocation of AUF1. Cytokine 56, 245–255. doi: 10.1016/j.cyto.2011.\n\n06.006\n\nYu, W., Chen, J., Xiong, Y., Pixley, F. J., Yeung, Y. G., and Stanley, E. R. (2012).\n\nMacrophage proliferation is regulated through CSF-1 receptor tyrosines 544,\n\n559, and 807. J. Biol. Chem. 287, 13694–13704. doi: 10.1074/jbc.M112.355610\n\nZhang, Y., Leung, D. Y., Richers, B. N., Liu, Y., Remigio, L. K., Riches, D. W., et al.\n\n(2012). Vitamin D inhibits monocyte/macrophage proinflammatory cytokine\n\nproduction by targeting MAPK phosphatase-1. J. Immunol. 188, 2127–2135.\n\ndoi: 10.4049/jimmunol.1102412\n\nZhao, Q., Wang, X., Nelin, L. D., Yao, Y., Matta, R., Manson, M. E., et al. (2006).\n\nMAP kinase phosphatase 1 controls innate immune responses and suppresses\n\nendotoxic shock. J. Exp. Med. 203, 131–140. doi: 10.1084/jem.20051794\n\nFrontiers in Molecular Biosciences | www.frontiersin.org 7 June 2016 | Volume 3 | Article 28\n\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org\nhttp://www.frontiersin.org/Molecular_Biosciences/archive\n\n\nLloberas et al. Macrophages and Mitogen Kinase Phosphatase 1\n\nZhong, H., Suyang, H., Erdjument-Bromage, H., Tempst, P., and Ghosh, S.\n\n(1997). The transcriptional activity of NF-kappaB is regulated by the IkappaB-\n\nassociated PKAc subunit through a cyclic AMP-independent mechanism. Cell\n\n89, 413–424. doi: 10.1016/S0092-8674(00)80222-6\n\nZhu, Q. Y., Liu, Q., Chen, J. X., Lan, K., and Ge, B. X. (2010). MicroRNA-\n\n101 targets MAPK phosphatase-1 to regulate the activation of MAPKs\n\nin macrophages. J. Immunol. 185, 7435–7442. doi: 10.4049/jimmunol.10\n\n00798\n\nZiegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., et al.\n\n(2010). Nomenclature of monocytes and dendritic cells in blood. Blood 116,\n\ne74–e80. doi: 10.1182/blood-2010-02-258558\n\nConflict of Interest Statement: The authors declare that the research was\n\nconducted in the absence of any commercial or financial relationships that could\n\nbe construed as a potential conflict of interest.\n\nCopyright © 2016 Lloberas, Valverde-Estrella, Tur, Vico and Celada. This is an\n\nopen-access article distributed under the terms of the Creative Commons Attribution\n\nLicense (CC BY). The use, distribution or reproduction in other forums is permitted,\n\nprovided the original author(s) or licensor are credited and that the original\n\npublication in this journal is cited, in accordance with accepted academic practice.\n\nNo use, distribution or reproduction is permitted which does not comply with these\n\nterms.\n\nFrontiers in Molecular Biosciences | www.frontiersin.org 8 June 2016 | Volume 3 | Article 28\n\nhttp://creativecommons.org/licenses/by/4.0/\nhttp://creativecommons.org/licenses/by/4.0/\nhttp://creativecommons.org/licenses/by/4.0/\nhttp://creativecommons.org/licenses/by/4.0/\nhttp://creativecommons.org/licenses/by/4.0/\nhttp://www.frontiersin.org/Molecular_Biosciences\nhttp://www.frontiersin.org\nhttp://www.frontiersin.org/Molecular_Biosciences/archive\n\n\tMitogen-Activated Protein Kinases and Mitogen Kinase Phosphatase 1: A Critical Interplay in Macrophage Biology\n\tMacrophages a key Element of the Immune System\n\tMAPKs and Macrophage Biology\n\tThe MKP-1 Phosphatase and Its Regulation\n\tThe Switch Between Proliferation and Activation is Mediated by MKP-1\n\tOther Activities Regulated By MKP-1\n\tAuthor Contributions\n\tAcknowledgments\n\tReferences\n\n\n'}